Year archive

Schott Pharma — 2023 filings

All 23 regulatory filings released by Schott Pharma (1SXP) in 2023, sourced directly from the official regulator.

23 Filings

2023 Period

2023 filings (23)

Filing	Released	Lang
SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance Earnings Release FY 2023	2023-12-19	English
2023 December Declarations of Corporate Governance (german) Governance Information	2023-12-18	German
2023 Dezember Erklärung zur Unternehmensführung Governance Information	2023-12-18	German
2023 Dezember Entprechenserklärung Governance Information	2023-12-15	German
2023 December Declarations of Conformity (German) Governance Information	2023-12-15	German
Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company Regulatory Filings	2023-12-06	English
Rules of procedure of the Executive Board (German) Governance Information	2023-12-05	German
Rules of procedure of the Supervisory Board (German) Governance Information	2023-12-05	German
Satzung der Gesellschaft Governance Information	2023-12-05	German
Articles of association of the company (German) Governance Information	2023-12-05	German
SCHOTT Pharma IPO: Early termination of stabilization period and full exercise of the Greenshoe Option Regulatory Filings	2023-10-06	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-10-05	German
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-10-05	German
SCHOTT Pharma AG & Co. KGaA: Andreas Reisse, buy Director's Dealing	2023-10-05	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-09-29	German
Release of the Home Member State according to Article 5 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Regulatory Filings	2023-09-29	English
SCHOTT Pharma IPO: Final offer price set at EUR 27.00 per share Share Issue/Capital Change	2023-09-27	English
SCHOTT Pharma AG & Co. KGaA: Final offer price for shares in SCHOTT Pharma set at EUR 27.00 per share Share Issue/Capital Change	2023-09-27	English
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma shares to be offered within price range of EUR 24.50 to EUR 28.50 per share Share Issue/Capital Change	2023-09-18	English
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma plans Initial Public Offering Capital/Financing Update	2023-09-06	English
Jahresabschluss zum Geschäftsjahr vom 28.01.2022 bis zum 30.09.2022 Annual Report FY 2022	2023-08-07	German
SCHOTT Pharma AG & Co. KGaA: Upholding momentum: SCHOTT Pharma sustains strong growth in the first half of FY 2023 Earnings Release H1 2023	2023-06-22	English
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma with strong financial performance in fiscal year 2022 Earnings Release FY 2022	2023-01-26	English